SlideShare a Scribd company logo
1 of 27
P-Plk1
a-tub
DAPI
P
The Cell Division Cycle
Mechanims and Implications in Disease
M. Malumbres
Spanish National Cancer Research Centre (CNIO)
The Cell Division Cycle
Plk1 is a cell cycle (Ser/Thr) kinase
involved in centrosome maturation, chromosome attachment and cytokinesis
Plk1 in the Cell Division Cycle
Plk1 inhibition
Mol Cancer Ther 2006;5(4)
Plk1
inhibitors
DMSO
Plk1 inhibition leads to mitotic arrest and cell death in vitro and in
vivo
Volasertib
(BI6727),
“Breakthroug
h Therapy”
designation
by the FDA in
acute myeloid
leukemia
(AML)
Plk1 inhibitors in Clinical Trials
What is the physiological role of Plk1 at the
organism level?
ATG TGA
Plk1(lox) 1 2 3 4 5 6 7 8 9 10
ATG TGA
Plk1(loxfrt) 1 2 3 4 5 6 7 8 9 10
neo
ATG TGA
Plk1(–) 1 3 4 5 6 7 8 9 10
Flp
Cre
Plk1 mouse models
pCMV rtTA TRE - pCMV Flag-Plk1 cDNA
Rosa26 rtTA Collagen locus cDNA integration
DOX
ON - OFF
low - HIGH
Loss-of-fuction
Gain-of-fuction
Plk1(+/+) Plk1(–/–) Plk1(–/–)
a-tub
DAPI
a-tub
DAPI
Plk1(+/+) Plk1(–/–)
ACA
Embryonic lethality in Plk1-null embryos
Plk1 is essential for mitosis in vivo
Plk1 heterozygous mice
Plk1(+/-) mice display: abnormal brain development
Increased brain
volume
Plk1 is regulates asymmetric cell división in neural progenitor cells
Plk1 heterozygous mice
Plk1(+/-) mice display: abnormal brain development
cardiovascular defects
Age (months)
Plk1(+/+)
Plk1(+/–)
Plk1(+/–) ♀
Plk1(+/–) ♂
Survival (%)
(from cardiovascular death)
**
0 6 12 18 24
40
60
80
100
**
**
Plk1 heterozygous mice
Plk1(+/-) mice display: abnormal brain development
cardiovascular defects
Plk1(+/–)
Plk1(+/+)
Abnormal structure of arterias in Plk1(+/-) mice
AS
DIA
SR
Structural alterations in the arterial elastic layer & lost of elasticity
Increase internal diameter in arteries & aneurisms
Plk1 is induced upon hypertension
(Plk1_lox)
X
(SM22a-CreERT2)
Specific ablation of Plk1 in Smooth Muscle Cells
Plk1 (lox/lox) (D/D)SM
lox
D
M - H A H A
- TMX + TMX
(H) - heart (A) - aorta
Specific ablation in
arterias
Hypotension
Specific ablation of Plk1 in Smooth Muscle Cells
10 weeks old
Angiotensin II
Deficient contraction Protected from
hypertension
Lack of contraction of actomyosin fibers
Smooth muscle cells isolated from mutant mice
Actomyosin contraction is a RhoA-dependent process
Plk1 re-localizes to contraction areas
Plk1 inhibitors prevent vascular funcion
Plk1 inhibitors induce breaks in the aorta
And cooperate with hypertension (AngII) in inducing vascular defects
Plk1 inhibitors induce breaks and aneurisms
AngII
+ DMSO
AngII
+ Volasertib
H&E
EVG
de Carcer et al. Nat Med 2017
Molecular mechanism?
Plk1 phosphorylated a RhoA-
GAP and recruits Ect2, a
RhoA Exchange factor
RhoA
ROCK
MLC
Plk1MYPT1
VASOCONSTRICTORS
VASCULAR
CONTRACTION
ECT2
RacGap1
p115-GEF aPKC
P-Plk1
a-tub
DAPI
P
Anaphase Telophase
Cytokinesis
Active
Plk1
Active
Plk1
A conserved mechanism in Plk1 function
Plk1  RhoA
Cytokinesis Blood pressure
PLk1
Contraction
A syndrome with Plk1 haploinsufficiency
Ballif et al. (2007) Nat. Genet. 39:107
PLK1
Skull phenotype
− Head circumference
− Flat face
− Frontal bossing
− Short nose with wide nasal bridge
Psychomotor and Cognitive delay
Cardiovasular disease
Take-Home messages
Plk1 is a major regulator of RhoA activity during acto-myosin
contraction:
a conserved function from yeast to mammals
a conserved function from proliferating to differentiated
cells
not only in cytokinesis: also during contraction of arterias
Mouse models provide a unique system to understand the
physiological relevance of proteins; hopefully before their inhibitors
reach the Clinic
Arteria function and structure should be monitored during therapeutic
treatments with volasertib against cancer (e.g. AML)
Mónica Alvarez-
Fernández
Guillermo de Cárcer
Aisha El-Bakali
José González-Martínez
Begoña Hurtado
Carolina Maestre
María Maroto
Diego Martínez-Alonso
Anna F. B. Martins
Marianna Trakala
María Salazar-Roa
Belén Sanz
María Sanz Flores
Elisabet Zapatero
X. Bustelo, M.A. Sevilla, M.J. Montero (CIC, Univ. Salamanca)
S. Martínez-Martínez, J. Oller, N. Méndez-Barbero, J.M. Redondo (CNIC)
Cell Division and Cancer Group
Spanish National Cancer Research Centre (CNIO)

More Related Content

What's hot

Platelet rich plasma
Platelet rich plasma Platelet rich plasma
Platelet rich plasma Atanu Kayal
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASAdam Schindler
 
Anti coagulationin patient with ckd Prof.Basset El Essawy MD ph D
Anti coagulationin patient with ckd Prof.Basset El Essawy  MD ph DAnti coagulationin patient with ckd Prof.Basset El Essawy  MD ph D
Anti coagulationin patient with ckd Prof.Basset El Essawy MD ph DFarragBahbah
 
Differential regulation of transient receptor potential melastatin 6 and 7 ca...
Differential regulation of transient receptor potential melastatin 6 and 7 ca...Differential regulation of transient receptor potential melastatin 6 and 7 ca...
Differential regulation of transient receptor potential melastatin 6 and 7 ca...Aliny Vasconcelos
 
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...星云 王
 
Erythropoietin- Kokate
Erythropoietin- KokateErythropoietin- Kokate
Erythropoietin- KokateADITI PETWAL
 
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...giafede
 
Enzyme~clinical enzymology
Enzyme~clinical enzymologyEnzyme~clinical enzymology
Enzyme~clinical enzymologyAlok Kumar
 
Presentation intro 1
Presentation intro 1Presentation intro 1
Presentation intro 1tckryan
 
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.Dmitri Popov
 

What's hot (20)

Bile acids and fxr and nsaids
Bile acids and fxr and nsaidsBile acids and fxr and nsaids
Bile acids and fxr and nsaids
 
Emergency warfarin reversal a
Emergency warfarin reversal aEmergency warfarin reversal a
Emergency warfarin reversal a
 
Platelet rich plasma
Platelet rich plasma Platelet rich plasma
Platelet rich plasma
 
Enzymes
EnzymesEnzymes
Enzymes
 
Schindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNASSchindler and Schekman 2009 PNAS
Schindler and Schekman 2009 PNAS
 
SOT Poster Final 2016
SOT Poster Final 2016SOT Poster Final 2016
SOT Poster Final 2016
 
Morelli Lecture 2014
Morelli Lecture 2014Morelli Lecture 2014
Morelli Lecture 2014
 
Anti coagulationin patient with ckd Prof.Basset El Essawy MD ph D
Anti coagulationin patient with ckd Prof.Basset El Essawy  MD ph DAnti coagulationin patient with ckd Prof.Basset El Essawy  MD ph D
Anti coagulationin patient with ckd Prof.Basset El Essawy MD ph D
 
Parathyroid Gland
Parathyroid GlandParathyroid Gland
Parathyroid Gland
 
Differential regulation of transient receptor potential melastatin 6 and 7 ca...
Differential regulation of transient receptor potential melastatin 6 and 7 ca...Differential regulation of transient receptor potential melastatin 6 and 7 ca...
Differential regulation of transient receptor potential melastatin 6 and 7 ca...
 
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
A reading report for <A Secreted Slit2 Fragment Regulates Adipose Tissue Ther...
 
Spio cytokinejan28
Spio cytokinejan28Spio cytokinejan28
Spio cytokinejan28
 
Erythropoietin- Kokate
Erythropoietin- KokateErythropoietin- Kokate
Erythropoietin- Kokate
 
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...
Lactate stimulates vasculogenic stem cells via the thioredoxin system and eng...
 
20200219 Shinya Oki
20200219 Shinya Oki20200219 Shinya Oki
20200219 Shinya Oki
 
Enzyme~clinical enzymology
Enzyme~clinical enzymologyEnzyme~clinical enzymology
Enzyme~clinical enzymology
 
Enzymology part2
Enzymology part2Enzymology part2
Enzymology part2
 
Nitric oxide
Nitric oxideNitric oxide
Nitric oxide
 
Presentation intro 1
Presentation intro 1Presentation intro 1
Presentation intro 1
 
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.
Radiation Protection: Phospholipase C, LAMP and Phopholipase C, LAMP inhibition.
 

Similar to Marcos Malumbres - Centro Nacional de Investigaciones Oncológica (CNIO). (20)

sodapdf-converted.pptx
sodapdf-converted.pptxsodapdf-converted.pptx
sodapdf-converted.pptx
 
229 propagermanium
229 propagermanium229 propagermanium
229 propagermanium
 
229 propagermanium
229 propagermanium229 propagermanium
229 propagermanium
 
Esv2n24
Esv2n24Esv2n24
Esv2n24
 
Characterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic miceCharacterization of gfp expression in lck 1 gfp transgenic mice
Characterization of gfp expression in lck 1 gfp transgenic mice
 
Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010Poster Filippa Pettersson ICDT 2010
Poster Filippa Pettersson ICDT 2010
 
CDD 2016
CDD 2016CDD 2016
CDD 2016
 
Akt/ Protein kinase B
Akt/ Protein kinase BAkt/ Protein kinase B
Akt/ Protein kinase B
 
3846573 (6)
3846573 (6)3846573 (6)
3846573 (6)
 
Prostaglandins, leukotrienes, (Eicosanoids) and.pptx
Prostaglandins, leukotrienes, (Eicosanoids) and.pptxProstaglandins, leukotrienes, (Eicosanoids) and.pptx
Prostaglandins, leukotrienes, (Eicosanoids) and.pptx
 
Graduate Seminar - Halloween 2009
Graduate Seminar - Halloween 2009Graduate Seminar - Halloween 2009
Graduate Seminar - Halloween 2009
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
1246.full.pdf
1246.full.pdf1246.full.pdf
1246.full.pdf
 
Veabmpnum
VeabmpnumVeabmpnum
Veabmpnum
 
Chronic myelogenous leukemia
Chronic myelogenous leukemiaChronic myelogenous leukemia
Chronic myelogenous leukemia
 
Autophagy: implications in neurodegeneration, fitness exercise and beyond
Autophagy: implications in neurodegeneration, fitness exercise and beyondAutophagy: implications in neurodegeneration, fitness exercise and beyond
Autophagy: implications in neurodegeneration, fitness exercise and beyond
 
Cell death
Cell deathCell death
Cell death
 
JBC2
JBC2JBC2
JBC2
 
Esv2n37 b
Esv2n37 bEsv2n37 b
Esv2n37 b
 
242 lipid lowering
242 lipid lowering242 lipid lowering
242 lipid lowering
 

More from Fundación Ramón Areces

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Fundación Ramón Areces
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...Fundación Ramón Areces
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Fundación Ramón Areces
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Fundación Ramón Areces
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Fundación Ramón Areces
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Fundación Ramón Areces
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...Fundación Ramón Areces
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...Fundación Ramón Areces
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Fundación Ramón Areces
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Fundación Ramón Areces
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Fundación Ramón Areces
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Fundación Ramón Areces
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Fundación Ramón Areces
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Fundación Ramón Areces
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Fundación Ramón Areces
 

More from Fundación Ramón Areces (20)

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
 

Recently uploaded

Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physicsvishikhakeshava1
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...Sérgio Sacani
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsAArockiyaNisha
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxAleenaTreesaSaji
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfSELF-EXPLANATORY
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxkessiyaTpeter
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSérgio Sacani
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 

Recently uploaded (20)

9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physics
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
 
Natural Polymer Based Nanomaterials
Natural Polymer Based NanomaterialsNatural Polymer Based Nanomaterials
Natural Polymer Based Nanomaterials
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Luciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptxLuciferase in rDNA technology (biotechnology).pptx
Luciferase in rDNA technology (biotechnology).pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdfBehavioral Disorder: Schizophrenia & it's Case Study.pdf
Behavioral Disorder: Schizophrenia & it's Case Study.pdf
 
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptxSOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
SOLUBLE PATTERN RECOGNITION RECEPTORS.pptx
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 

Marcos Malumbres - Centro Nacional de Investigaciones Oncológica (CNIO).

  • 1. P-Plk1 a-tub DAPI P The Cell Division Cycle Mechanims and Implications in Disease M. Malumbres Spanish National Cancer Research Centre (CNIO)
  • 3. Plk1 is a cell cycle (Ser/Thr) kinase involved in centrosome maturation, chromosome attachment and cytokinesis Plk1 in the Cell Division Cycle
  • 4. Plk1 inhibition Mol Cancer Ther 2006;5(4) Plk1 inhibitors DMSO Plk1 inhibition leads to mitotic arrest and cell death in vitro and in vivo
  • 5. Volasertib (BI6727), “Breakthroug h Therapy” designation by the FDA in acute myeloid leukemia (AML) Plk1 inhibitors in Clinical Trials
  • 6. What is the physiological role of Plk1 at the organism level?
  • 7. ATG TGA Plk1(lox) 1 2 3 4 5 6 7 8 9 10 ATG TGA Plk1(loxfrt) 1 2 3 4 5 6 7 8 9 10 neo ATG TGA Plk1(–) 1 3 4 5 6 7 8 9 10 Flp Cre Plk1 mouse models pCMV rtTA TRE - pCMV Flag-Plk1 cDNA Rosa26 rtTA Collagen locus cDNA integration DOX ON - OFF low - HIGH Loss-of-fuction Gain-of-fuction
  • 8. Plk1(+/+) Plk1(–/–) Plk1(–/–) a-tub DAPI a-tub DAPI Plk1(+/+) Plk1(–/–) ACA Embryonic lethality in Plk1-null embryos
  • 9. Plk1 is essential for mitosis in vivo
  • 10. Plk1 heterozygous mice Plk1(+/-) mice display: abnormal brain development Increased brain volume Plk1 is regulates asymmetric cell división in neural progenitor cells
  • 11. Plk1 heterozygous mice Plk1(+/-) mice display: abnormal brain development cardiovascular defects Age (months) Plk1(+/+) Plk1(+/–) Plk1(+/–) ♀ Plk1(+/–) ♂ Survival (%) (from cardiovascular death) ** 0 6 12 18 24 40 60 80 100 ** **
  • 12. Plk1 heterozygous mice Plk1(+/-) mice display: abnormal brain development cardiovascular defects Plk1(+/–) Plk1(+/+)
  • 13. Abnormal structure of arterias in Plk1(+/-) mice AS DIA SR Structural alterations in the arterial elastic layer & lost of elasticity Increase internal diameter in arteries & aneurisms
  • 14. Plk1 is induced upon hypertension
  • 15. (Plk1_lox) X (SM22a-CreERT2) Specific ablation of Plk1 in Smooth Muscle Cells Plk1 (lox/lox) (D/D)SM lox D M - H A H A - TMX + TMX (H) - heart (A) - aorta Specific ablation in arterias Hypotension
  • 16. Specific ablation of Plk1 in Smooth Muscle Cells 10 weeks old Angiotensin II Deficient contraction Protected from hypertension
  • 17. Lack of contraction of actomyosin fibers Smooth muscle cells isolated from mutant mice Actomyosin contraction is a RhoA-dependent process
  • 18. Plk1 re-localizes to contraction areas
  • 19. Plk1 inhibitors prevent vascular funcion
  • 20. Plk1 inhibitors induce breaks in the aorta And cooperate with hypertension (AngII) in inducing vascular defects
  • 21. Plk1 inhibitors induce breaks and aneurisms AngII + DMSO AngII + Volasertib H&E EVG de Carcer et al. Nat Med 2017
  • 22. Molecular mechanism? Plk1 phosphorylated a RhoA- GAP and recruits Ect2, a RhoA Exchange factor RhoA ROCK MLC Plk1MYPT1 VASOCONSTRICTORS VASCULAR CONTRACTION ECT2 RacGap1 p115-GEF aPKC
  • 24. A conserved mechanism in Plk1 function Plk1  RhoA Cytokinesis Blood pressure PLk1 Contraction
  • 25. A syndrome with Plk1 haploinsufficiency Ballif et al. (2007) Nat. Genet. 39:107 PLK1 Skull phenotype − Head circumference − Flat face − Frontal bossing − Short nose with wide nasal bridge Psychomotor and Cognitive delay Cardiovasular disease
  • 26. Take-Home messages Plk1 is a major regulator of RhoA activity during acto-myosin contraction: a conserved function from yeast to mammals a conserved function from proliferating to differentiated cells not only in cytokinesis: also during contraction of arterias Mouse models provide a unique system to understand the physiological relevance of proteins; hopefully before their inhibitors reach the Clinic Arteria function and structure should be monitored during therapeutic treatments with volasertib against cancer (e.g. AML)
  • 27. Mónica Alvarez- Fernández Guillermo de Cárcer Aisha El-Bakali José González-Martínez Begoña Hurtado Carolina Maestre María Maroto Diego Martínez-Alonso Anna F. B. Martins Marianna Trakala María Salazar-Roa Belén Sanz María Sanz Flores Elisabet Zapatero X. Bustelo, M.A. Sevilla, M.J. Montero (CIC, Univ. Salamanca) S. Martínez-Martínez, J. Oller, N. Méndez-Barbero, J.M. Redondo (CNIC) Cell Division and Cancer Group Spanish National Cancer Research Centre (CNIO)